Thromboembolic events in gastric cancer: High incidence in patients receiving irinotecan- and bevacizumab-based therapy Journal Article

  

Authors:	Shah, M. A.; Ilson, D.; Kelsen, D. P.
Article Title:	Thromboembolic events in gastric cancer: High incidence in patients receiving irinotecan- and bevacizumab-based therapy
Keywords:	clinical trial; bevacizumab; cisplatin; antineoplastic agent; letter; phase 2 clinical trial; antineoplastic combined chemotherapy protocols; incidence; camptothecin; risk factors; risk factor; irinotecan; monoclonal antibody; antibodies, monoclonal; thromboembolism; chemically induced disorder; drug derivative; stomach cancer; informed consent; stomach neoplasms; stomach tumor; thrombophilia
Journal Title:	Journal of Clinical Oncology
Volume:	23
Issue:	11
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2005-04-10
Start Page:	2574
End Page:	2576
Language:	English
DOI:	10.1200/jco.2005.81.908
PUBMED:	15795413
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-17844373871&partnerID=40&md5=f4ca5b36788b077f62fff6751ebb9990
Notes:	--- - "Cited By (since 1996): 88" - "Export Date: 24 October 2012" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/35854